Similar articles

• Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach.

  Moroncini G, Cuccioloni M, Mozzicafreddo M, Pozniak KN, Grieco A, Paolini C, Tonnini C, Spadoni T, Svegliati S, Funaro A, Angeletti M, Gabrielli A. Moroncini G, et al. Anal Biochem. 2017 Jul 1;528:26-33. doi: 10.1016/j.ab.2017.04.011. Epub 2017 Apr 24. Anal Biochem. 2017. PMID: 28450104
• Undifferentiated Connective Tissue Disease at risk for systemic sclerosis (SSc) (so far referred to as very early/early SSc or pre-SSc).

  Valentini G. Valentini G. Autoimmun Rev. 2015 Mar;14(3):210-3. doi: 10.1016/j.autrev.2014.11.002. Epub 2014 Nov 18. Autoimmun Rev. 2015. PMID: 25461837 Review.
• Agonistic antibodies in systemic sclerosis.

  Moroncini G, Svegliati Baroni S, Gabrielli A. Moroncini G, et al. Immunol Lett. 2018 Mar;195:83-87. doi: 10.1016/j.imlet.2017.10.007. Epub 2017 Oct 13. Immunol Lett. 2018. PMID: 29032187 Review.
• Agonistic Anti-PDGF Receptor Autoantibodies from Patients with Systemic Sclerosis Impact Human Pulmonary Artery Smooth Muscle Cells Function In Vitro.

  Svegliati S, Amico D, Spadoni T, Fischetti C, Finke D, Moroncini G, Paolini C, Tonnini C, Grieco A, Rovinelli M, Funaro A, Gabrielli A. Svegliati S, et al. Front Immunol. 2017 Feb 8;8:75. doi: 10.3389/fimmu.2017.00075. eCollection 2017. Front Immunol. 2017. PMID: 28228756 Free PMC article.
• Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis.

  Moroncini G, Grieco A, Nacci G, Paolini C, Tonnini C, Pozniak KN, Cuccioloni M, Mozzicafreddo M, Svegliati S, Angeletti M, Kazlauskas A, Avvedimento EV, Funaro A, Gabrielli A. Moroncini G, et al. Arthritis Rheumatol. 2015 Jul;67(7):1891-903. doi: 10.1002/art.39125. Arthritis Rheumatol. 2015. PMID: 25808833